Sale and Purchase of Ivermectin
The passage of H0029 represents a significant change in how ivermectin is handled within state law. By permitting the OTC sale of ivermectin, the bill seeks to ease access for individuals who wish to obtain this medication without the need for a prescription. Proponents may argue that this added accessibility could aid individuals who require ivermectin for conditions that can be treated effectively with the medication.
House Bill H0029 proposes a new regulation concerning the sale and purchase of ivermectin in the state of Florida, specifically allowing it to be sold as an over-the-counter (OTC) medication. The bill specifically creates Section 381.993 in the Florida Statutes, which defines what constitutes an OTC medication and explicitly states that ivermectin suitable for human use may be sold without a prescription or consultation with a healthcare provider. This legislation is set to come into effect on July 1, 2026.
While the bill may be seen as a step towards greater accessibility of certain medications, it could also spark debate over public health and safety. Opponents may raise concerns about the potential misuse of ivermectin, especially given its controversial use during health crises such as the COVID-19 pandemic. Furthermore, allowing OTC sales may undermine guidelines recommended by healthcare professionals regarding the appropriate use of the drug, which could lead to improper self-medication by the public.